Agenda At A Glance
Plenary Sessions – Next Generation Innovations
Workshop A
Workshop B
Workshop C
Innovating the Future of Cell Therapy with Next Generation Gene Editing
Unlocking the Power of Cord Blood as a Platform for Scalable Manufacturing of Universal Cell Therapy Products
Navigating Through a New Complex Regulatory Landscape to Drive Future Product Development
Workshop D
Workshop E
Workshop F
Moving to the Future: Translating Product Development for an ‘Offthe- Shelf’ World Beyond Oncology
Manufacturing Challenges: Large Scale Complex Editing of Cell Therapy Products
Turning a Universal Dream into a Commercial Reality
Industry Leader’s Fireside Chat
Plenary Sessions - Spotlight on Clinical Validation
Pre-Clinical
Translational
Manufacturing
Supply/Storage
Novel Gene Engineering Strategies for Greater Safety & Efficacy of Response
Advancing Donor-Derived Approaches with Enhanced Screening & Selection
Improving Scalability to Bring the True Promise of Allogeneic Products to Life
Optimizing Cryopreservation to Revolutionize the Cold Supply Chain
Advancing Safety with Innovations in Gene Editing
Overcoming Allogeneic Graft Rejection for Greater Patient Outcomes
Enhancing Efficiency of Delivery with Non-Viral Manufacturing
Rethinking Donor Cell Source & Selection for a Smoother Supply Chain
Utilizing Alternative Effector Cells for an Off-the-Shelf Approach
Tackling Graft Versus Host Disease to Reduce Treatment- Related Mortality
Developing a Safe and Consistent Allogeneic Product for Commercial Readiness
Optimizing Sourcing & Testing of Allogeneic Starting Material to Ensure Consistency in Supply
Pre-Clinical
Translational
Manufacturing
Supply/Storage
Supercharging Solid Tumor Targeting for Broader Success
Conquering the Tumor Microenvironment to Drive Efficacy of Response
Driving Automated Manufacturing Processes for Successful Commercialisation of Allogenic Therapies
Enhancing Cold-Chain Shipping & Storage to Deliver Truly Off-the Shelf Products
Pioneering the Innovations in Gene Engineering for Enhanced Efficacy of Response
Unveiling the Tools and Strategies to Maximize Efficiency in IND Filing
Reviewing the Paradigm of Characterization & Strategical Viability Testing
Revolutionizing Data Management & Integration
Plenary Sessions – Ushering in the Next Wave of Universal Cell Therapy: Future Directions
Advancing Durability & Persistence
Improving Persistence of Allogeneic Immune Cells for Longer Lasting Therapies
Advancing Durability to Overcome Patient Relapse Following Allogeneic Cell Therapy Treatment
Rethinking Dosing Strategies and Lymphodepletion Regimens to Optimize Persistence & Efficacy